MARKET WIRE NEWS
  1. Home
  2. Stock
  3. ESPR
  4. News
ESPR
Quote
Short
News
Articles
Message Board

Esperion Therapeutics Inc. (NASDAQ : ESPR ) News

Esperion Therapeutics Inc. (NASDAQ: ESPR) News Releases

ESPR News Releases
ESPR : NASDAQ
Canada Newswire
HLS Therapeutics Announces NILEMDOTM (bempedoic acid) is now available in Canada for the Reduction of LDL-Cholesterol in Patients at Risk of Cardiovascular Disease
ESPR : NASDAQ
SeekingAlpha
Esperion Therapeutics, Inc. (ESPR) M&A Call Transcript
ESPR : NASDAQ
SeekingAlpha
Esperion to acquire Corstasis for $75M upfront payment
ESPR : NASDAQ
GlobeNewswire
Esperion Therapeutics and Corstasis Therapeutics Announce Esperion's Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst(TM) (bumetanide nasal spray)
ESPR : NASDAQ
KlickAnalytics
ESPR - Historical Earnings Price Analysis
ESPR : NASDAQ
GlobeNewswire
Esperion to Report Fourth Quarter and Full Year 2025 Financial Results on March 10
ESPR : NASDAQ
GlobeNewswire
Esperion to Participate in The 2026 Citizens Life Sciences Conference
ESPR : NASDAQ
SeekingAlpha
Esperion Therapeutics: Past The Turnaround, Waiting On Guidelines
ESPR : NASDAQ
GlobeNewswire
Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
ESPR : NASDAQ
SeekingAlpha
Top Quant rated bullish small cap stocks among companies with high short interest

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.